Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab

CARE-MS I, CARE-MS II, and CAMMS03409 Investigators

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Lymphocyte pharmacodynamics are not associated with autoimmunity or efficacy after alemtuzumab'. Together they form a unique fingerprint.

Medicine & Life Sciences